Calcium and vitamin D in obesity

Nutrition Research Reviews

Volumn 25, Issue 1, 2012, Pages 130-141

  Song, Qingming ^a   Sergeev, Igor N ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

1,25 Dihydroxyvitamin D3; Adipocytes; Apoptosis; Calcium; Intracellular Ca2+; Obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CALCIUM LACTATE; CALCIUM PHOSPHATE; CASPASE 12; CASPASE 3; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; APOPTOSIS; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM DEFICIENCY; CALCIUM INTAKE; CALCIUM METABOLISM; CELL DIFFERENTIATION; DAIRY PRODUCT; DIET SUPPLEMENTATION; ENERGY BALANCE; EXCRETION; FAT EXCRETION; FECES; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; LIPID METABOLISM; NONHUMAN; OBESITY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; APOPTOSIS; BODY COMPOSITION; BODY WEIGHT; CALCIUM, DIETARY; DIET; DIETARY FATS; ENERGY METABOLISM; HUMANS; MICRONUTRIENTS; OBESITY; VITAMIN D;

EID: 84863663452     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422412000029     Document Type: Review

References (137)

1. Giskes K, van Lenthe F, Avendano-Pabon M, et al. (2011) A systematic review of environmental factors and obesogenic dietary intakes among adults: are we getting closer to understanding obesogenic environments? Obes Rev 12, e95-e106.
2. World Health Organization (2009) Obesity and overweight. index.html
3. Ogden CL, Yanovski SZ, Carroll MD, et al. (2007) The epidemiology of obesity. Gastroenterology 132, 2087-2102.
4. Maury E & Brichard SM (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1-16.
5. Solomon CG & Manson JE (1997) Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 66, 1044S-1050S.
6. Hedley AA, Ogden CL, Johnson CL, et al. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291, 2847-2850.
7. United States Department of Agriculture (2010) Lossadjusted food availability. FoodConsumption/FoodGuideIndex.htm#calories
8. Maes HH, Neale MC & Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27, 325-351.
9. Lane MD & Tang QQ (2005) From multipotent stem cell to adipocyte. Birth Defects Res A Clin Mol Teratol 73, 476-477.
10. Clement K, Vaisse C, Lahlou N, et al. (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398-401.
11. Gesta S, Tseng YH & Kahn CR (2007) Developmental origin of fat: tracking obesity to its source. Cell 131, 242-256.
12. Abate N & Garg A (1995) Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 34, 53-70.
13. Porter SA, Massaro JM, Hoffmann U, et al. (2009) Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 32, 1068-1075.
14. Yusuf S, Hawken S, Ounpuu S, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952.
15. Haugen F & Drevon CA (2007) The interplay between nutrients and the adipose tissue. Proc Nutr Soc 66, 171-182.
16. Ashton KG (2002) Patterns of within-species body size variation of birds: strong evidence for Bergmann's rule. Global Ecol and Biogeogr 11, 505-523.
17. Narvaez CJ, Matthews D, Broun E, et al. (2009) Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150, 651-661.
18. Guerre-Millo M (2002) Adipose tissue hormones. J Endocrinol Invest 25, 855-861.
19. Fliers E & Boelen A (2010) Type 2 deiodinase and brown fat: the heat is on - or off. Endocrinology 151, 4087-4089.
20. Carafoli E, Santella L, Branca D, et al. (2001) Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 36, 107-260.
21. Sergeev IN, Rhoten WB & Spirichev VB (1998) Vitamin D and intracellular calcium. Subcell Biochem 30, 271-297.
22. Sergeev IN (2005) Calcium signaling in cancer and vitamin D. J Steroid Biochem Mol Biol 97, 145-151.
23. Sergeev IN (2009) 1,25-Dihydroxyvitamin D3 induces Ca2'- mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem Biophys Res Commun 384, 18-21.
24. Sergeev IN & Norman AW (2000) 1,25-Dihydroxyvitamin D3 and calcium signaling. In Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects, pp. 715-718 [AW Norman, R Bouillon and M Thomasset, editors]. Riverside: University of California.
25. Sergeev IN & Rhoten WB (1995) 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic b-cell line. Endocrinology 136, 2852-2861.
26. Institute of Medicine (2011) Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press.
27. United States Department of Agriculture (2010) Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. Washington, DC: USDA.
28. Scientific Panel on Dietetic Products, Nutrition and Allergies (2006) Tolerable Upper Intake Levels for Vitamins and Minerals. Scientific Committee on Food. Parma: European Food Safety Authority.
29. Heaney RP (2006) Calcium intake and disease prevention. Arq Bras Endocrinol Metabol 50, 685-693.
30. Wright JD, Wang CY, Kennedy-Stephenson J, et al. (2003) Dietary intake of ten key nutrients for public health, United States: 1999-2000. Adv Data 334, 1-4.
31. National Institutes of Health (1994) Optimal calcium intake. 1994OptimalCalcium097html.htm
32. Pilvi TK, Harala S, Korpela R, et al. (2009) Effects of highcalcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL/6J mice. Br J Nutr 102, 337-341.
33. Eller LK & Reimer RA (2010) A high calcium, skim milk powder diet results in a lower fat mass in male, energy-restricted, obese rats more than a low calcium, casein, or soy protein diet. J Nutr 140, 1234-1241.
34. Parra P, Bruni G, Palou A, et al. (2008) Dietary calcium attenuation of body fat gain during high-fat feeding in mice. J Nutr Biochem 19, 109-117.
35. de Wit NJ, Bosch-Vermeulen H, Oosterink E, et al. (2011) Supplementary dietary calcium stimulates faecal fat and bile acid excretion, but does not protect against obesity and insulin resistance in C57BL/6J mice. Br J Nutr 105, 1005-1011.
36. Leite LH & Sampaio AB (2010) Dietary calcium, dairy food intake and metabolic abnormalities in HIV-infected individuals. J Hum Nutr Diet 23, 535-543.
37. Dicker D, Belnic Y, Goldsmith R, et al. (2008) Relationship between dietary calcium intake, body mass index, and waist circumference in MABAT - the Israeli NationalHealth and Nutrition Study. Isr Med Assoc J 10, 512-515.
38. dos Santos LC, de Padua Cintra I, Fisberg M, et al. (2008)Calcium intake and its relationship with adiposity and insulinresistance in post-pubertal adolescents. J Hum Nutr Diet21, 109-116.
39. Palacios C, Benedetti P & Fonseca S (2007) Impact of calcium intake on body mass index in Venezuelanadolescents. P R Health Sci J 26, 199-204.
40. Gonzalez AJ, White E, Kristal A, et al. (2006) Calcium intakeand 10-year weight change in middle-aged adults. J AmDiet Assoc 106, 1066-1073.
41. Tidwell DK & ValliantMW(2011) Higher amounts of body fatare associated with inadequate intakes of calcium and vitaminD in African American women. Nutr Res 31, 527-536.
42. Goldberg TB, da Silva CC, Peres LN, et al. (2009) Calciumintake and its relationship with risk of overweight andobesity in adolescents. Arch Latinoam Nutr 59, 14-21.
43. Torres MR, da Silva Ferreira T, Carvalho DC, et al. (2010)Dietary calcium intake and its relationship with adiposityand metabolic profile in hypertensive patients. Nutrition 6, 666-671.
44. Wagner G, Kindrick S, Hertzler S, et al. (2007) Effects of various forms of calcium on body weight and bone turnover markers in women participating in a weight loss program.J Am Coll Nutr 26, 456-461.
45. Faghih S, Abadi AR, Hedayati M, et al. (2011) Comparisonof the effects of cows' milk, fortified soy milk, and calcium supplement on weight and fat loss in premenopausal overweightand obese women. Nutr Metab Cardiovasc Dis 21, 499-503.
46. Teegarden D, White KM, Lyle RM, et al. (2008) Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16, 1566-1572.
47. Riedt CS, Schlussel Y, von Thun N, et al. (2007) Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr 85, 972-980.
48. Thomas DT, Wideman L & Lovelady CA (2010) Effects of calcium and resistance exercise on body composition in overweightpremenopausal women. J Am Coll Nutr 29, 604-611.
49. Yanovski JA, Parikh SJ, Yanoff LB, et al. (2009) Effects of calcium supplementation on body weight and adiposity in overweight and obese adults: a randomized trial. Ann Intern Med 150, 821-829.
50. Chailurkit LO, Saetung S, Thakkinstian A, et al. (2010) Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin Endocrinol (Oxf) 73, 167-172.
51. Trowman R, Dumville JC, Hahn S, et al. (2006) A systematic review of the effects of calcium supplementation on body weight. Br J Nutr 95, 1033-1038.
52. Torres MR, Francischetti EA, Genelhu V, et al. (2010) Effect of a high-calcium energy-reduced diet on abdominal obesity and cardiometabolic risk factors in obese Brazilian subjects. Int J Clin Pract 64, 1076-1083.
53. Norman AW (1979) Vitamin D: The Calcium Homeostatic Steroid Hormone. New York: Academic Press.
54. Spirichev VB & Sergeev IN (1988) Vitamin D: experimental research and its practical application. World Rev Nutr Diet 56, 173-216.
55. Sergeev IN, Rhoten WB & Norman AW (1997) 1,25-Dihydroxyvitamin D3, intracellular Ca2' and apoptosis in breast cancer cells. In Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, pp.473-474 [AW Norman, R Bouillon and M Thomasset, editors]. Riverside: University of California.
56. Sergeev IN & Rhoten WB (1998) Regulation of intracellular calcium in human breast cancer cells. Endocrine 9, 321-327.
57. Norman AW, Nemere I, Zhou LX, et al. (1992) 1,25(OH)2- vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41, 231-240.
58. Sergeev IN (2009) Novel mediators of vitamin D signaling in cancer and obesity. Immunol Endocr Metab Agents Med Chem 9, 153-158.
59. Nemere I, Garbi N, Hammerling GJ, et al. (2010) Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor/PDIA3/Erp57. J Biol Chem 285, 31859-31866.
60. Nemere I & Hintze K (2008) Novel hormone "receptors". J Cell Biochem 103, 401-407.
61. Sergeev IN & Spirichev VB (1989) Are the receptors of 1,25-dihydroxyvitamin D3 vitamin K dependent? Biochemistry (Mosc) 54, 1325-1330.
62. Norman AW, Sergeev IN, Bishop JE, et al. (1993) Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues. Cancer Res 53, 3935-3942.
63. Farach-Carson MC, Sergeev IN & Norman AW (1991) Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 129, 1876-1884.
64. Norman AW & Silva FR (2001) Structure function studies: identification of vitamin D analogs for the ligand-binding domains of important proteins in the vitamin D-endocrine system. Rev Endocr Metab Disord 2, 229-238.
65. Sergeev IN (2004) Calcium as a mediator of 1,25-dihydroxyvitamin D3-induced apoptosis. J Steroid Biochem Mol Biol 89-90, 419-425.
66. Sergeev IN & Rhoten WB (1998) Intracellular calcium, the vitamin D hormone and apoptosis in breast cancer cells. Mol Biol Cell 9, 251a.
67. Sergeev IN, Rhoten WB & Carney MD (1996) Calbindins decreased after space flight. Endocrine 5, 335-340.
68. Sergeev IN & Rhoten WB (1995) Video imaging of calcium and pH in breast-cancer cells. Mol Biol Cell 6, 2039.
69. Rhoten WB & Sergeev IN (1994) Calbindin-D28k appears to buffer intracellular Ca2' in butyrate-treated rat insulinoma cells. Endocrine 2, 989-995.
70. Sergeev IN & Spirichev VB (1988) The role of vitamin K in the interaction of 1,25-dihydroxyvitamin D3 receptors with DNA (article in Russian). Biull Eksp Biol Med 106, 695-698.
71. Sergeev IN & Norman AW (1992) Vitamin-K-dependent g-carboxylation of the 1,25-dihydroxyvitamin-D3 receptor. Biochem Biophys Res Commun 189, 1543-1547.
72. Holick MF (1997) Photobiology of vitamin D. In Vitamin D, pp. 33-39 [D Feldman, FH Glorieux and JW Pike, editors]. San Diego: Academic Press.
73. Verreault R, Semba RD, Volpato S, et al. (2002) Low serum vitamin D does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc 50, 912-917.
74. Norman AW & Bouillon R (2010) Vitamin D nutritional policy needs a vision for the future. Exp Biol Med 235, 1034-1045.
75. Foss YJ (2009) Vitamin D deficiency is the cause of common obesity. Med Hypotheses 72, 314-321.
76. Rosenstreich SJ, Rich C & Volwiler W (1971) Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest 50 679-687.
77. Zemel MB, Shi H, Greer B, et al. (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132-1138.
78. Aasheim ET, Hofso D, Hjelmesaeth J, et al. (2008) Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 87, 362-369.
79. Alemzadeh R, Kichler J, Babar G, et al. (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57, 183-191.
80. Ardawi MS, Qari MH, Rouzi AA, et al. (2011) Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 22, 463-475.
81. Beydoun MA, Boueiz A, Shroff MR, et al. (2010) Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 95, 3814-3827.
82. Brock K, Huang WY, Fraser DR, et al. (2010) Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middleaged men and women. J Steroid Biochem Mol Biol 121, 462-466.
83. Elizondo-Montemayor L, Ugalde-Casas PA, Serrano-Gonzalez M, et al. (2010) Serum 25-hydroxyvitamin D concentration, life factors and obesity in Mexican children. Obesity (Silver Spring) 18, 1805-1811.
84. Herranz Antolin S, Garcia Martinez Mdel C & Alvarez De Frutos V (2010) Vitamin D deficiency in morbidly obese patients.A case-control study. Endocrinol Nutr 57, 256-261.
85. Hypponen E & Power C (2006) Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 29, 2244-2246.
86. Konradsen S, Ag H, Lindberg F, et al. (2008) Serum 1,25- dihydroxyvitamin D is inversely associated with body mass index. Eur J Nutr 47, 87-91.
87. Kremer R, Campbell PP, Reinhardt T, et al. (2009) Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 94, 67-73.
88. Lagunova Z, Porojnicu AC, Lindberg F, et al. (2009) The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 29, 3713-3720.
89. Reinehr T, de Sousa G, Alexy U, et al. (2007) Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 157, 225-232.
90. Smotkin-Tangorra M, Purushothaman R, Gupta A, et al. (2007) Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 20, 817-823.
91. Valina-Toth AL, Lai Z, Yoo W, et al. (2010) Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 72, 595-603.
92. Vilarrasa N, Maravall J, Estepa A, et al. (2007) Low 25- hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 30, 653-658.
93. Yanoff LB, Parikh SJ, Spitalnik A, et al. (2006) The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese black Americans. Clin Endocrinol (Oxf) 64, 523-529.
94. Adam MA, Untch BR, Danko ME, et al. (2010) Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J Clin Endocrinol Metab 95, 4917-4924.
95. Johnson LK, Hofsø D, Aasheim ET, et al. (2012) Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study. Eur J Clin Nutr 66, 83-90.
96. Pacifico L, Anania C, Osborn JF, et al. (2011) Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol 165, 603-611.
97. Renzaho AM, Halliday JA & Nowson C (2011) Vitamin D, obesity, and obesity-related chronic disease among ethnic minorities: a systematic review. Nutrition 27, 868-879.
98. Vashi PG, Lammersfeld CA, Braun DP, et al. (2011) Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J 10, 51.
99. Rajakumar K, de las Heras J, Chen TC, et al. (2011) Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab 96, 1560-1567.
100. Lagunova Z, Porojnicu AC, Lindberg FA, et al. (2011) Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr Diabetes 12, 120-126.
101. World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, WHO Technical Report Series no. 894. Geneva: WHO.
102. Sharma S, Barr AB, Macdonald HM, et al. (2011) Vitamin D deficiency and disease risk among aboriginal Arctic populations. Nutr Rev 69, 468-478.
103. Mawer EB, Backhouse J, Holman CA, et al. (1972) The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43, 413-431.
104. Zittermann A, Frisch S, Berthold HK, et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321-1327.
105. Sneve M, Figenschau Y & Jorde R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159, 675-684.
106. Major GC, Alarie F, Dore J, et al. (2007) Supplementation with calcium ' vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 85, 54-59.
107. Holecki M, Zahorska-Markiewicz B, Wiecek A, et al. (2008) Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts 1, 274-279.
108. Zhou J, Zhao LJ, Watson P, et al. (2010) The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab (Lond) 7, 62.
109. Caan B, Neuhouser M, Aragaki A, et al. (2007) Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 167, 893-902.
110. Buchowski MS, Aslam M, Dossett C, et al. (2010) Effect of dairy and non-dairy calcium on fecal fat excretion in lactose digester and maldigester obese adults. Int J Obes (Lond) 34, 127-135.
111. Christensen R, Lorenzen JK, Svith CR, et al. (2009) Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev 10, 475-486.
112. Reed JC (2002) Apoptosis-based therapies. Nat Rev Drug Discov 1, 111-121.
113. Prins JB & O'Rahilly S (1997) Regulation of adipose cell number in man. Clin Sci (Lond) 92, 3-11.
114. Berridge MJ, Bootman MD & Lipp P (1998) Calcium - a life and death signal. Nature 395, 645-648.
115. Orrenius S, Zhivotovsky B & Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4, 552-565.
116. Sergeev IN, Colby J & Norman AW (2000) 1,25-Dihydroxyvitamin D3 triggers calcium-mediated apoptosis in breast cancer cells. In Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects, pp. 399-402 [AW Norman, R Bouillon and M Thomasset, editors]. Riverside: University of California.
117. Mathiasen IS, Sergeev IN, Bastholm L, et al. (2002) Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 277, 30738-30745.
118. Sergeev IN & Norman AW (2003) Calcium as a mediator of apoptosis in bovine oocytes and preimplantation embryos. Endocrine 22, 169-176.
119. McConkey DJ & Orrenius S (1997) The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 239, 357-366.
120. Welsh J, VanWeelden K, Flanagan L, et al. (1998) The role of vitamin D3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Subcell Biochem 30, 245-270.
121. Carafoli E & Molinari M (1998) Calpain: a protease in search of a function? Biochem Biophys Res Commun 247, 193-203.
122. Ho PK & Hawkins CJ (2005) Mammalian initiator apoptotic caspases. FEBS J 272, 5436-5453.
123. Oubrahim H, Chock PB & Stadtman ER (2002) Manganese( II) induces apoptotic cell death in NIH3T3 cells via a caspase-12-dependent pathway. J Biol Chem 277 20135-20138.
124. Nakagawa T, Zhu H, Morishima N, et al. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-b. Nature 403, 98-103.
125. Welsh J & Byrne B (2007) Identification of novel mediators of vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells. J Steroid Biochem Mol Biol 103, 703-707.
126. Sergeev IN, Li S, Ho CT, et al. (2009) Polymethoxyflavones activate Ca2'-dependent apoptotic targets in adipocytes. J Agric Food Chem 57, 5771-5776.
127. Sergeev IN, Ho CT, Li S, et al. (2007) Apoptosis-inducing activity of hydroxylated polymethoxyflavones and polymethoxyflavones from orange peel in human breast cancer cells. Mol Nutr Food Res 51, 1478-1484.
128. Sergeev IN, Li S, Colby J, et al. (2006) Polymethoxylated flavones induce Ca2'-mediated apoptosis in breast cancer cells. Life Sci 80, 245-253.
129. Kong J & Li YC (2006) Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290, E916-E924.
130. Jones JR, Barrick C, Kim KA, et al. (2005) Deletion of PPARg in adipose tissues of mice protects against high fat dietinduced obesity and insulin resistance. Proc Natl Acad Sci U S A 102, 6207-6212.
131. Clarke SL, Robinson CE & Gimble JM (1997) CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor g2 promoter. Biochem Biophys Res Commun 240, 99-103.
132. Blumberg JM, Tzameli I, Astapova I, et al. (2006) Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 281, 11205-11213.
133. Zemel MB & Sun X (2008) Calcitriol and energy metabolism. Nutr Rev 66, S139-S146.
134. Sampath V, Havel PJ & King JC (2008) Calcium supplementation does not alter lipid oxidation or lipolysis in overweight/ obese women. Obesity (Silver Spring) 16, 2400-2404.
135. Bortolotti M, Rudelle S, Schneiter P, et al. (2008) Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism. Am J Clin Nutr 88, 877-885.
136. Nedergaard J, Ricquier D & Kozak LP (2005) Uncoupling proteins: current status and therapeutic prospects. EMBO Rep 6, 917-921.
137. Sun X & Zemel MB (2004) Role of uncoupling protein 2 (UCP2) expression and 1a, 25-dihydroxyvitamin D3 in modulating adipocyte apoptosis. FASEB J 18, 1430-1432.